Evercore Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24.9M Sell
27,054
-7,792
-22% -$7.9M 0.39% 49
2025
Q4
$37.4M Buy
34,846
+503
+1% +$481K 0.55% 41
2025
Q3
$26.2M Sell
34,343
-1,604
-4% -$1.19M 0.38% 48
2025
Q2
$28M Sell
35,947
-599
-2% -$465K 0.44% 44
2025
Q1
$30.2M Sell
36,546
-653
-2% -$543K 0.48% 44
2024
Q4
$28.7M Sell
37,199
-67
-0.2% -$55.5K 0.43% 46
2024
Q3
$33M Sell
37,266
-3,220
-8% -$2.89M 0.5% 41
2024
Q2
$36.7M Sell
40,486
-52
-0.1% -$41.6K 0.58% 42
2024
Q1
$31.5M Sell
40,538
-5,469
-12% -$3.89M 0.49% 44
2023
Q4
$26.8M Sell
46,007
-834
-2% -$487K 0.45% 45
2023
Q3
$25.2M Sell
46,841
-748
-2% -$385K 0.47% 46
2023
Q2
$22.3M Sell
47,589
-693
-1% -$291K 0.41% 48
2023
Q1
$16.6M Sell
48,282
-1,167
-2% -$394K 0.33% 48
2022
Q4
$18.1M Sell
49,449
-121
-0.2% -$42.9K 0.38% 49
2022
Q3
$16M Sell
49,570
-75
-0.2% -$23.8K 0.36% 50
2022
Q2
$16.1M Sell
49,645
-1,634
-3% -$490K 0.34% 51
2022
Q1
$14.7M Sell
51,279
-1,327
-3% -$342K 0.26% 58
2021
Q4
$14.5M Sell
52,606
-1,800
-3% -$456K 0.24% 59
2021
Q3
$12.6M Sell
54,406
-1,860
-3% -$459K 0.23% 59
2021
Q2
$12.9M Sell
56,266
-2,845
-5% -$571K 0.24% 57
2021
Q1
$11M Sell
59,111
-2,443
-4% -$478K 0.22% 62
2020
Q4
$10.4M Sell
61,554
-1,230
-2% -$184K 0.22% 61
2020
Q3
$9.29M Buy
62,784
+240
+0.4% +$37.1K 0.23% 61
2020
Q2
$10.3M Sell
62,544
-176
-0.3% -$27K 0.27% 60
2020
Q1
$8.7M Sell
62,720
-8,174
-12% -$1.12M 0.29% 58
2019
Q4
$9.32M Sell
70,894
-467
-0.7% -$54.1K 0.25% 63
2019
Q3
$7.98M Sell
71,361
-1,750
-2% -$195K 0.23% 68
2019
Q2
$8.1M Buy
73,111
+1,646
+2% +$194K 0.25% 66
2019
Q1
$9.27M Sell
71,465
-1,852
-3% -$225K 0.3% 63
2018
Q4
$8.48M Sell
73,317
-658
-0.9% -$73.5K 0.32% 62
2018
Q3
$7.94M Sell
73,975
-3,817
-5% -$382K 0.25% 70
2018
Q2
$6.64M Buy
77,792
+53,840
+225% +$4.42M 0.23% 73
2018
Q1
$1.85M Sell
23,952
-420
-2% -$33.8K 0.07% 136
2017
Q4
$2.06M Sell
24,372
-1,460
-6% -$124K 0.08% 134
2017
Q3
$2.21M Sell
25,832
-182
-0.7% -$14.9K 0.09% 126
2017
Q2
$2.14M Buy
26,014
+1
+0% +$82 0.08% 129
2017
Q1
$2.19M Buy
26,013
+2,916
+13% +$234K 0.09% 129
2016
Q4
$1.7M Sell
23,097
-3,042
-12% -$227K 0.07% 141
2016
Q3
$2.1M Buy
26,139
+483
+2% +$38.7K 0.09% 129
2016
Q2
$2.02M Sell
25,656
-1,592
-6% -$120K 0.09% 127
2016
Q1
$1.96M Sell
27,248
-1,161
-4% -$87.8K 0.09% 125
2015
Q4
$2.39M Buy
28,409
+1,788
+7% +$148K 0.11% 121
2015
Q3
$2.23M Sell
26,621
-167
-0.6% -$14.1K 0.11% 120
2015
Q2
$2.23M Sell
26,788
-3,886
-13% -$296K 0.1% 126
2015
Q1
$2.23M Sell
30,674
-2,412
-7% -$172K 0.1% 128
2014
Q4
$2.28M Sell
33,086
-4,523
-12% -$305K 0.11% 119
2014
Q3
$2.44M Buy
37,609
+9,091
+32% +$576K 0.12% 130
2014
Q2
$1.77M Buy
28,518
+23,440
+462% +$1.4M 0.09% 141
2014
Q1
$299K Buy
5,078
+375
+8% +$20.9K 0.02% 324
2013
Q4
$240K Buy
4,703
+1,000
+27% +$50.1K 0.01% 346
2013
Q3
$185K Buy
3,703
+439
+13% +$23K 0.01% 405
2013
Q2
$160K Buy
+3,264
New +$178K 0.01% 426

Other funds holding LLY

Evercore Wealth Management's LLY Position: Q1 2026 in Review

Evercore Wealth Management reduced its Eli Lilly (LLY) stake by 22% in Q1 2026, selling an estimated $7.9M and leaving 27,054 shares worth $24.9M. The position accounts for 0.39% of the portfolio, ranked #49.

Evercore Wealth Management first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $37.4M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Evercore Wealth Management held 27,054 shares of Eli Lilly worth $24.9M as of Q1 2026.
  • Evercore Wealth Management sold 7,792 Eli Lilly shares in Q1 2026, an estimated $7.9M.
  • Eli Lilly made up 0.39% of Evercore Wealth Management's portfolio in Q1 2026, its #49 holding.
  • Evercore Wealth Management first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Evercore Wealth Management's Eli Lilly position peaked at $37.4M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Evercore Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.